• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Occup Environ Hyg . Assessment and mitigation of aerosol airborne SARS-CoV-2 transmission in laboratory and office environments

tetano

Editor, Senior Moderator
J Occup Environ Hyg


. 2020 Sep 22;1-10.
doi: 10.1080/15459624.2020.1805117. Online ahead of print.
Assessment and mitigation of aerosol airborne SARS-CoV-2 transmission in laboratory and office environments


Benjamin L Augenbraun[SUP] 1 2 [/SUP], Zack D Lasner[SUP] 1 2 [/SUP], Debayan Mitra[SUP] 1 2 [/SUP], Sridhar Prabhu[SUP] 1 2 [/SUP], Shivam Raval[SUP] 1 2 [/SUP], Hiromitsu Sawaoka[SUP] 1 2 [/SUP], John M Doyle[SUP] 1 2 [/SUP]



Affiliations

Abstract

Bioaerosols are known to be an important transmission pathway for SARS-CoV-2. We report a framework for estimating the risk of transmitting SARS-CoV-2 via aerosols in laboratory and office settings, based on an exponential dose-response model and analysis of air flow and purification in typical heating, ventilation, and air conditioning (HVAC) systems. High-circulation HVAC systems with high-efficiency particulate air (HEPA) filtration dramatically reduce exposure to the virus in indoor settings, and surgical masks or N95 respirators further reduce exposure. As an example of our risk assessment model, we consider the precautions needed for a typical experimental physical science group to maintain a low risk of transmission over six months of operation. We recommend that, for environments where fewer than five individuals significantly overlap, work spaces should remain vacant for between one (high-circulation HVAC with HEPA filtration) to six (low-circulation HVAC with no filtration) air exchange times before a new worker enters in order to maintain no more than 1% chance of infection over six months of operation in the workplace. Our model is readily applied to similar settings that are not explicitly given here. We also provide a framework for evaluating infection mitigation through ventilation in multiple occupancy spaces.

Keywords: Airborne viral transmission; SARS-CoV-2; coronavirus; risk analysis.
 
Back
Top Bottom